Imeik Technology Development Co
Imeik Technology Development Co.,Ltd. engages in the research and development, production, and transformation of biomedical soft tissue repair materials in China. The company offers aesthetic medicine products, including cross-linked sodium hyaluronate gel with PLLA-b-PEG microsphere, poly facial implant thread, medical sodium hyaluronate-hydroxypropyl methylcellulose gel, sodium hyaluronate comp… Read more
Imeik Technology Development Co (300896) - Net Assets
Latest net assets as of September 2025: CN¥7.98 Billion CNY
Based on the latest financial reports, Imeik Technology Development Co (300896) has net assets worth CN¥7.98 Billion CNY as of September 2025.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (CN¥8.70 Billion) and total liabilities (CN¥713.18 Million). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | CN¥7.98 Billion |
| % of Total Assets | 91.8% |
| Annual Growth Rate | 56.87% |
| 5-Year Change | 75.45% |
| 10-Year Change | 5141.97% |
| Growth Volatility | 166.24 |
Imeik Technology Development Co - Net Assets Trend (2014–2024)
This chart illustrates how Imeik Technology Development Co's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for Imeik Technology Development Co (2014–2024)
The table below shows the annual net assets of Imeik Technology Development Co from 2014 to 2024.
| Year | Net Assets | Change |
|---|---|---|
| 2024-12-31 | CN¥7.95 Billion | +22.59% |
| 2023-12-31 | CN¥6.49 Billion | +9.07% |
| 2022-12-31 | CN¥5.95 Billion | +18.21% |
| 2021-12-31 | CN¥5.03 Billion | +11.00% |
| 2020-12-31 | CN¥4.53 Billion | +583.75% |
| 2019-12-31 | CN¥662.70 Million | +63.74% |
| 2018-12-31 | CN¥404.74 Million | +23.28% |
| 2017-12-31 | CN¥328.31 Million | +23.66% |
| 2016-12-31 | CN¥265.49 Million | +75.06% |
| 2015-12-31 | CN¥151.66 Million | +72.23% |
| 2014-12-31 | CN¥88.06 Million | -- |
Equity Component Analysis
This analysis shows how different components contribute to Imeik Technology Development Co's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have grown by 6006.3% over the analyzed period, indicating profitable operations and earnings retention.
Current Equity Component Breakdown (December 2024)
| Component | Amount | Percentage |
|---|---|---|
| Retained Earnings | CN¥4.38 Billion | 56.12% |
| Common Stock | CN¥302.59 Million | 3.88% |
| Other Comprehensive Income | CN¥131.59 Million | 1.69% |
| Other Components | CN¥2.99 Billion | 38.31% |
| Total Equity | CN¥7.80 Billion | 100.00% |
Imeik Technology Development Co Competitors by Market Cap
The table below lists competitors of Imeik Technology Development Co ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Offcn Education Technology Co Ltd
SHE:002607
|
$2.32 Billion |
|
Leyard Optoelectronic
SHE:300296
|
$2.32 Billion |
|
Chorus Limited
PINK:CHRUF
|
$2.32 Billion |
|
GCL System Integration Technology Co Ltd
SHE:002506
|
$2.32 Billion |
|
Sai Gon Ha Noi Commercial Joint Stock Bank
VN:SHB
|
$2.32 Billion |
|
Hainan Drinda Automotive Trim Co Ltd
SHE:002865
|
$2.32 Billion |
|
BOK Financial Corporation
NASDAQ:BOKF
|
$2.32 Billion |
|
DHT Holdings Inc
NYSE:DHT
|
$2.32 Billion |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Imeik Technology Development Co's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2023 to 2024, total equity changed from 6,347,942,275 to 7,797,060,228, a change of 1,449,117,953 (22.8%).
- Net income of 1,957,596,834 contributed positively to equity growth.
- Dividend payments of 499,895,952 reduced retained earnings.
- Other comprehensive income decreased equity by 28,103,740.
Equity Change Factors (2023 to 2024)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | CN¥1.96 Billion | +25.11% |
| Dividends Paid | CN¥499.90 Million | -6.41% |
| Other Comprehensive Income | CN¥-28.10 Million | -0.36% |
| Other Changes | CN¥19.52 Million | +0.25% |
| Total Change | CN¥- | 22.83% |
Book Value vs Market Value Analysis
This analysis compares Imeik Technology Development Co's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 5.52x
- The company is trading at a significant premium to its book value, suggesting the market values its earnings potential, brand, or other intangibles highly.
- The price-to-book ratio has decreased from 251.37x to 5.52x over the analyzed period, indicating reduced market premium.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2014-12-31 | CN¥0.57 | CN¥142.84 | x |
| 2015-12-31 | CN¥0.98 | CN¥142.84 | x |
| 2016-12-31 | CN¥1.70 | CN¥142.84 | x |
| 2017-12-31 | CN¥2.00 | CN¥142.84 | x |
| 2018-12-31 | CN¥2.47 | CN¥142.84 | x |
| 2019-12-31 | CN¥3.05 | CN¥142.84 | x |
| 2020-12-31 | CN¥20.95 | CN¥142.84 | x |
| 2021-12-31 | CN¥23.25 | CN¥142.84 | x |
| 2022-12-31 | CN¥27.02 | CN¥142.84 | x |
| 2023-12-31 | CN¥20.98 | CN¥142.84 | x |
| 2024-12-31 | CN¥25.89 | CN¥142.84 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Imeik Technology Development Co utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 25.11%
- The company demonstrates strong efficiency in generating profits from shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 64.70%
- • Asset Turnover: 0.36x
- • Equity Multiplier: 1.07x
- Recent ROE (25.11%) is above the historical average (24.68%), indicating improving capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2014 | 32.27% | 37.83% | 0.71x | 1.20x | CN¥19.61 Million |
| 2015 | 11.64% | 15.79% | 0.65x | 1.14x | CN¥2.49 Million |
| 2016 | 20.31% | 37.93% | 0.45x | 1.19x | CN¥27.09 Million |
| 2017 | 25.29% | 36.94% | 0.56x | 1.22x | CN¥49.69 Million |
| 2018 | 30.84% | 38.27% | 0.69x | 1.16x | CN¥83.01 Million |
| 2019 | 46.37% | 54.78% | 0.75x | 1.13x | CN¥239.63 Million |
| 2020 | 9.70% | 62.00% | 0.15x | 1.02x | CN¥-13.63 Million |
| 2021 | 19.05% | 66.16% | 0.28x | 1.05x | CN¥455.03 Million |
| 2022 | 21.61% | 65.17% | 0.31x | 1.07x | CN¥678.95 Million |
| 2023 | 29.28% | 64.77% | 0.42x | 1.08x | CN¥1.22 Billion |
| 2024 | 25.11% | 64.70% | 0.36x | 1.07x | CN¥1.18 Billion |
Industry Comparison
This section compares Imeik Technology Development Co's net assets metrics with peer companies in the Medical Instruments & Supplies industry.
Industry Context
- Industry: Medical Instruments & Supplies
- Average net assets among peers: $2,246,530,775
- Average return on equity (ROE) among peers: 12.28%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Imeik Technology Development Co (300896) | CN¥7.98 Billion | 32.27% | 0.09x | $2.32 Billion |
| Beijing Centergate Technologies Holding Co Ltd (000931) | $2.03 Billion | -9.26% | 2.64x | $356.80 Million |
| Blue Sail Medical Co Ltd (002382) | $10.54 Billion | 10.97% | 0.61x | $763.05 Million |
| Andon Health Co Ltd (002432) | $758.75 Million | 1.34% | 0.32x | $2.12 Billion |
| Allmed Medical Products Co Ltd Class A (002950) | $2.75 Billion | 15.67% | 0.82x | $346.13 Million |
| Guangzhou Improve Med Instrument (300030) | $592.55 Million | 4.90% | 0.10x | $234.74 Million |
| Shanghai Tofflon Science Tech (300171) | $2.41 Billion | 11.06% | 0.57x | $784.88 Million |
| Truking Technology Ltd (300358) | $320.32 Million | 29.77% | 1.35x | $545.42 Million |
| Jiangxi Sanxin Medtec Co Ltd (300453) | $1.41 Billion | 16.14% | 0.58x | $438.45 Million |
| Shenyang Xingqi Pharmaceutical Co Ltd (300573) | $1.55 Billion | 13.64% | 0.15x | $1.62 Billion |
| Autek China Inc (300595) | $105.24 Million | 28.59% | 0.10x | $1.21 Billion |